Alterity Therapeutics (ASX:ATH) – Webinar Presentation

Dr David Stamler – CEO – Alterity Therapeutics (ASX:ATH) is a clinical stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.